MIP-1 alpha increases the self-renewal capacity of the hemopoietic spleen-colony-forming cells following hydroxyurea treatment in vivo.
Authors
Lord, Brian IAffiliation
CRC Department of Experimental Haematology, Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Manchester, UK.Issue Date
1995
Metadata
Show full item recordAbstract
In this report, the effect of macrophage inflammatory protein (MIP-1alpha) on the self-renewal, in vivo, of haemopoietic spleen colony-forming units (CFU-S) following cytotoxic damage, has been investigated. CFU-S recovery following injection of hydroxyurea, HU (1 g/kg at 0 and 7 hers) with or without MIP-1alpha intervention was measured over the following 5 days. In addition to the initial protection conferred by MIP-1alpha, the CFU-S population recovered about 1.7 times faster than in the unprotected controls. Direct measurement of the self-renewal capacity of the CFU-S population was made at 2 days after HU + MIP-1alpha treatment by measuring the number of CFU-S/spleen colony in a secondary transplant assay. CFU-S following HU treatment alone generated 60 CFU-S/colony. Additional MIP-1alpha treatment increased this to 90 CFU-S/colony. It is concluded that MIP-1alpha modifies the generation age structure of a regenerating CFU-S population such that recovery is initiated from the more primitive cells of the population's age spectrum and that this observation should extend the range of cytotoxic agents from which MIP-1alpha can give protection.Citation
MIP-1 alpha increases the self-renewal capacity of the hemopoietic spleen-colony-forming cells following hydroxyurea treatment in vivo. 1995, 12 (2):145-9 Growth FactorsJournal
Growth FactorsDOI
10.3109/08977199509028960PubMed ID
8679248Type
ArticleLanguage
enISSN
0897-7194ae974a485f413a2113503eed53cd6c53
10.3109/08977199509028960
Scopus Count
Collections
Related articles
- Macrophage-inflammatory protein protects multipotent hematopoietic cells from the cytotoxic effects of hydroxyurea in vivo.
- Authors: Lord BI, Dexter TM, Clements JM, Hunter MA, Gearing AJ
- Issue date: 1992 May 15
- BB-10010/MIP-1 alpha in vivo maintains haemopoietic recovery following repeated cycles of sublethal irradiation.
- Authors: Lord BI, Marshall E, Woolford LB, Hunter MG
- Issue date: 1996 Oct
- Identification and characterization of an inhibitor of haemopoietic stem cell proliferation.
- Authors: Graham GJ, Wright EG, Hewick R, Wolpe SD, Wilkie NM, Donaldson D, Lorimore S, Pragnell IB
- Issue date: 1990 Mar 29
- Continuous infusion of macrophage inflammatory protein MIP-1alpha enhances leucocyte recovery and haemopoietic progenitor cell mobilization after cyclophosphamide.
- Authors: Marshall E, Woolford LB, Lord BI
- Issue date: 1997
- [Protection of hematopoietic stem cells by MIP-1alpha and PF4 against the cytotoxicity of chemotherapeutic agents].
- Authors: Huang K, Huang S, Pan J, Wu Y
- Issue date: 2000 Jul